
ABAStroke is a company developing digital solutions for neurological rehabilitation of cognitive deficits in stroke survivors. They combine Applied Behavior Analysis (ABA) methodology with machine learning (AI) algorithms to offer patients an unlimited variety of exercises for independent, personalized, and effective home-based treatment. A clinical study conducted in 2023-2024 with 74 participants showed that patients using ABAStroke achieved an average improvement of 3.69 points in the Montreal Cognitive Assessment (MoCA) test, which is 84% greater than the 2.00 points improvement seen in the control group receiving standard care. The company is focused on developing and certifying its solution, aiming to become a prescribable digital health app (SaMD) and is open to collaborations in neurorehabilitation.

ABAStroke is a company developing digital solutions for neurological rehabilitation of cognitive deficits in stroke survivors. They combine Applied Behavior Analysis (ABA) methodology with machine learning (AI) algorithms to offer patients an unlimited variety of exercises for independent, personalized, and effective home-based treatment. A clinical study conducted in 2023-2024 with 74 participants showed that patients using ABAStroke achieved an average improvement of 3.69 points in the Montreal Cognitive Assessment (MoCA) test, which is 84% greater than the 2.00 points improvement seen in the control group receiving standard care. The company is focused on developing and certifying its solution, aiming to become a prescribable digital health app (SaMD) and is open to collaborations in neurorehabilitation.
Product: Home-based mobile app for post-stroke cognitive rehabilitation
Tech: Applied Behavior Analysis (ABA) methodology + machine-learning personalization
Clinical evidence: 2023–2024 study (n=74): app users improved MoCA by 3.69 points vs 2.00 for control
Headquarters: Kraków (Cracow), Poland
Company stage: Pre-Seed (Crunchbase); reported investor: LSI (Life Science Innovations Fund)
Founded: 2020
Post-stroke cognitive rehabilitation
2020
Medtech / Digital therapeutics
Crunchbase lists one Pre-Seed round dated Dec 13, 2019 and LSI as funder
“LSI (Life Science Innovations Fund) participated in a Pre-Seed round (Dec 13, 2019)”